Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Breast Neoplasms 1

Interventions

Cisplatin 3193Cyclophosphamide 3187Carboplatin 2968Radiotherapy 2784Paclitaxel 2716Gemcitabine 2569pembrolizumab 2378Bevacizumab 2206Docetaxel 2196Fluorouracil 1848Capecitabine 1828Oxaliplatin 1738Dexamethasone 1604Nivolumab 1580Doxorubicin 1501Rituximab 1487Magnetic Resonance Spectroscopy 1382Etoposide 1345Irinotecan 1245Leucovorin 1222Drug Therapy 1202Cytarabine 1130Pemetrexed 1074fludarabine 1056Specimen Handling 1009Vincristine 964Cetuximab 943Prednisone 940Trastuzumab 940Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Multimodal Imaging × Clear all
NCT03285841 2024-03-18

OCT-AF Imaging of Pre-cancers of Vulva and Cervix

British Columbia Cancer Agency

Terminated
20 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Vulvar Neoplasms

NCT00804544 2012-03-05

99mTc-MIBI SPECT/CT in Breast Malignancy

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Terminated
4 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡